How do I interpret an ApoB trend across three draws?

I have the full paper rather than the abstract, and the supplementary appendix.

I can parse the result. I am less sure what it licenses me to conclude.

I have deliberately not looked at anyone else’s interpretation yet.

What is the correct interpretation, and what is the common misreading?

The relevant statistical point is that a ninety-five per cent reference interval means one analyte in twenty will read out of range in a healthy person by construction.

A sensible core for this population is a full blood count, renal function with electrolytes, liver enzymes with bilirubin, a fasting lipid panel with apolipoprotein B, HbA1c and thyroid-stimulating hormone.

Relative to absolute, worked

The last two rows describe the same finding. Only one of them is used in headlines.

Keep the reports rather than the numbers. Units, reference intervals and methods all vary, and a bare number two years later is not comparable to anything.

External quality assurance schemes document between-laboratory differences on common analytes that routinely exceed the size of clinically interesting changes.

Baseline first, then a repeat under identical conditions. Everything else is secondary.

The short version: a small, well-chosen panel with a baseline beats a large one without.

A twenty-analyte panel run on a healthy person will produce, on average, one out-of-range result purely from how reference intervals are constructed. That is arithmetic rather than pathology.

Worth being precise here: delta checks — comparing against your own previous value — are far more sensitive than comparing against a population interval, which is the argument for keeping a series rather than a snapshot.

Biological variation data are published per analyte and are the basis for the reference change value — the difference between two results that is larger than noise.

The caveat is that a panel is not a diagnosis and interpreting one is a clinician's job, particularly when several values move together.

Keep the full report, not the number. You will need the units and the interval later.

Before reacting to any single value, check whether it is outside the interval by an amount larger than the assay's own variation.

Repeat before you react. A single abnormal value has a substantial probability of being within the combined biological and analytical variation of a normal one.

Timing matters per analyte: cortisol and testosterone are diurnal, triglycerides are postprandial, and creatinine responds to hydration and to recent training. Fixing the conditions removes most of the noise.

Research-use compounds are not approved for human use, and no panel makes that safer.

Decide the action for each result before you order the test.

edited 30 Oct 2024 by kwn_analytical — added the placebo-arm figures

The honest position is that most people order too many analytes and too few time points, when the reverse would be more informative.

Same laboratory, same method, same time of day, same fasting state. Between-laboratory differences on several common analytes are larger than the changes people are trying to detect.

Ordering tests you will not act on generates anxiety and incidental findings, both of which have costs.

One out-of-range value on a twenty-analyte panel is expected. Two on a repeat is a finding.

Answer first: decide what you would do differently for each possible result before you order the panel. Anything that fails that test is a number you will worry about and not act on.

Haemolysis in the sample raises potassium and several enzymes spuriously. If a result is bizarre, ask whether the sample was flagged before building a theory on it.

Same laboratory, same time, same fasting state, or the comparison is not a comparison.